Several studies reported that taxane induces immunogenic cell death of cancer cells and causes various immunogenic actions, which creates favorable conditions to enhance the immune response of PD-1 inhibitors (Chan and Yang, 2000; Garnett et al., 2008; Galluzzi et al., 2020). This evidence concerns the gene PDCD1 and cancer.